ONTOLOGY REPORT - ANNOTATIONS
abnormal choroid vasculature morphology
|
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
IAGP |
4 |
13,471,878 |
13,525,620 |
RGD:2307226 |
RGD |
abnormal eye morphology
|
| G |
Pax6 |
paired box 6 |
|
|
QTM |
3 |
91,127,605 |
91,149,178 |
RGD:731242 |
RGD |
abnormal eye physiology
|
| G |
Pax6 |
paired box 6 |
|
|
IAGP |
3 |
91,127,605 |
91,149,178 |
RGD:1601213 |
RGD |
| G |
Pax6Sey |
paired box gene 6, small eye mutation |
|
|
IAGP |
|
|
|
RGD:1601213 |
RGD |
abnormal eye pigmentation
|
| S |
RCS-p+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:632096 |
RGD |
| S |
RCS/LavRrrc |
royal college of surgeons rat |
|
|
IED |
|
|
|
RGD:632096 |
RGD |
abnormal retina morphology
|
| S |
WF |
Wistar Furth |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
WF/Pit |
Wistar Furth |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
abnormal retinal apoptosis
|
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
|
IED |
1 |
201,385,705 |
201,388,987 |
RGD:1358731 |
RGD |
abnormal retinal pigmentation
|
| S |
RCS-p+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:632096 |
RGD |
| S |
RCS-rdy+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:1358250 |
RGD |
| S |
RCS-rdy+ p+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:1358250 |
RGD |
| S |
RCS/LavRrrc |
royal college of surgeons rat |
|
|
IED |
|
|
|
RGD:632096 |
RGD |
abnormal retinal vasculature morphology
|
| G |
Gh1 |
growth hormone 1 |
|
|
IEA |
10 |
95,692,240 |
95,694,117 |
RGD:704404 |
RGD |
| G |
Kdr |
kinase insert domain receptor |
|
|
IED |
|
|
|
RGD:1581593 |
RGD |
abnormal uvea morphology
|
| Q |
Eau1 |
Experimental allergic uveoretinitis QTL 1 |
|
|
QTM |
4 |
69,183,301 |
134,858,710 |
RGD:61073 |
RGD |
| Q |
Eau2 |
Experimental allergic uveoretinitis QTL 2 |
|
|
QTM |
12 |
1 |
29,130,348 |
RGD:61073 |
RGD |
| Q |
Eau3 |
Experimental allergic uveoretinitis QTL 3 |
|
|
QTM |
10 |
35,713,452 |
101,848,683 |
RGD:61073 |
RGD |
| Q |
Eau4 |
Experimental allergic uveoretinitis QTL 4 |
|
Induced |
IED |
3 |
139,485,124 |
171,063,335 |
RGD:2296064 |
RGD |
| Q |
Eau5 |
Experimental allergic uveoretinitis QTL 5 |
|
Induced |
IED |
2 |
210,636,008 |
247,306,073 |
RGD:2296064 |
RGD |
| Q |
Eau6 |
Experimental allergic uveoretinitis QTL 6 |
|
Induced |
IED |
7 |
90,478,161 |
135,478,161 |
RGD:2296064 |
RGD |
| Q |
Eau7 |
Experimental allergic uveoretinitis QTL 7 |
|
Induced |
IED |
10 |
35,713,561 |
36,254,741 |
RGD:2296064 |
RGD |
| Q |
Eau8 |
Experimental allergic uveoretinitis QTL 8 |
|
Induced |
IED |
19 |
19,112,825 |
59,218,465 |
RGD:2296064 |
RGD |
| Q |
Eau9 |
Experimental allergic uveoretinitis QTL 9 |
|
Induced |
IED |
10 |
69,160,380 |
86,317,054 |
RGD:2296064 |
RGD |
anophthalmia
|
| S |
MSUBL |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
cataracts
|
| G |
Brca2 |
breast cancer 2, early onset |
|
|
IAGP |
12 |
4,282,952 |
4,323,693 |
RGD:1599505 |
RGD |
| G |
Gja3 |
gap junction protein, alpha 3 |
|
Spontaneous |
NAS |
15 |
36,052,554 |
36,078,001 |
RGD:1599824 |
RGD |
| G |
Gja8 |
gap junction membrane channel protein alpha 8 |
|
|
IAGP |
|
|
|
RGD:629571 |
RGD |
| S |
F344/NHok |
|
|
|
TAS |
|
|
|
RGD:69668 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
TAS |
|
|
|
RGD:628479 |
RGD |
| S |
SHR-Gja8m1Cub |
|
|
|
IED |
|
|
|
RGD:2293186 |
RGD |
| S |
UPL/Cas |
Upjohn Pharmaceuticals Limited |
|
|
TAS |
|
|
|
RGD:727242 |
RGD |
| S |
UPL/Ncc |
|
|
|
TAS |
|
|
|
RGD:629571 |
RGD |
corneal opacity
|
| Q |
Cati1 |
Cataract Ihara QTL 1 |
|
|
QTM |
8 |
16,468,237 |
61,468,237 |
RGD:68701 |
RGD |
| Q |
Cati2 |
Cataract Ihara QTL 2 |
|
|
QTM |
15 |
16,458,810 |
61,458,810 |
RGD:68701 |
RGD |
| S |
PETH/N |
Royal College of Surgeons, RCS |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
SD/Rij |
|
|
|
IED |
|
|
|
RGD:628479 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
IED |
|
|
|
RGD:628479 |
RGD |
decreased retinal photoreceptor cell number
|
| S |
RCS/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
eye inflammation
|
| Q |
Eau1 |
Experimental allergic uveoretinitis QTL 1 |
|
Induced |
IED |
4 |
69,183,301 |
134,858,710 |
RGD:2296064 |
RGD |
| Q |
Eau2 |
Experimental allergic uveoretinitis QTL 2 |
|
Induced |
IED |
12 |
1 |
29,130,348 |
RGD:2296064 |
RGD |
| Q |
Eau3 |
Experimental allergic uveoretinitis QTL 3 |
|
Induced |
IED |
10 |
35,713,452 |
101,848,683 |
RGD:2296064 |
RGD |
| Q |
Eau4 |
Experimental allergic uveoretinitis QTL 4 |
|
Induced |
IED |
3 |
139,485,124 |
171,063,335 |
RGD:2296064 |
RGD |
| Q |
Eau5 |
Experimental allergic uveoretinitis QTL 5 |
|
Induced |
IED |
2 |
210,636,008 |
247,306,073 |
RGD:2296064 |
RGD |
| Q |
Eau6 |
Experimental allergic uveoretinitis QTL 6 |
|
Induced |
IED |
7 |
90,478,161 |
135,478,161 |
RGD:2296064 |
RGD |
| Q |
Eau7 |
Experimental allergic uveoretinitis QTL 7 |
|
Induced |
IED |
10 |
35,713,561 |
36,254,741 |
RGD:2296064 |
RGD |
| Q |
Eau8 |
Experimental allergic uveoretinitis QTL 8 |
|
Induced |
IED |
19 |
19,112,825 |
59,218,465 |
RGD:2296064 |
RGD |
| Q |
Eau9 |
Experimental allergic uveoretinitis QTL 9 |
|
Induced |
IED |
10 |
69,160,380 |
86,317,054 |
RGD:2296064 |
RGD |
| S |
LEW/NHsd |
|
|
Susceptibility |
IED |
|
|
|
RGD:2296064 |
RGD |
| S |
WKAH/Hok |
Wistar-King Aptekman Hokkaido |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
microphthalmia
|
| S |
BDII |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
CPB-WE |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
CWS |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
F344/NHok |
|
|
|
TAS |
|
|
|
RGD:69668 |
RGD |
| S |
MSUBL |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
SD-Pax6Sey |
|
|
|
IED |
|
|
|
RGD:1601213 |
RGD |
| S |
SHR-Gja8m1Cub |
|
|
|
IED |
|
|
|
RGD:2293186 |
RGD |
retinal degeneration
|
| S |
OM |
Osborne-Mendel |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
OM/N |
Osborne-Mendel |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
RCS-p+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:632096 |
RGD |
| S |
RCS-rdy+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:1358250 |
RGD |
| S |
RCS-rdy+ p+/LavRrrc |
|
|
|
IED |
|
|
|
RGD:1358250 |
RGD |
| S |
RCS/LavRrrc |
royal college of surgeons rat |
|
|
IED |
|
|
|
RGD:632096 |
RGD |
| S |
RCS/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
SD-Tg(P23H)1Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(P23H)2Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(P23H)3Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(S334ter)3Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(S334ter)3LavRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
| S |
SD-Tg(S334ter)4Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(S334ter)5Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(S334ter)7Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
SD-Tg(S334ter)9Lav |
|
|
|
TAS |
|
|
|
RGD:1358308 |
RGD |
| S |
WAG |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
thin retinal outer nuclear layer
|
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
IAGP |
4 |
13,471,878 |
13,525,620 |
RGD:2307226 |
RGD |
Term paths to the root
|